Cosmo Pharmaceuticals N.V.
SIX:COPN.SW
64.5 (CHF) • At close November 8, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CHF.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 92.78 | 102.089 | 65.074 | 60.949 | 62.495 | 65.617 | 67.242 | 67.664 | 60.607 | 79.593 | 56.368 | 59.537 | 33.509 | 32.05 | 26.685 | 34.173 | 21.9 | 15.158 | 15.506 | 11.03 |
| Kosten van de omzet
| 18.836 | 18.762 | 15.14 | 10.444 | 9.247 | 12.37 | 12.125 | 10.187 | 10.076 | 11.62 | 10.282 | 8.418 | 14.492 | 14.326 | 12.774 | 13.203 | 7.022 | 5.497 | 5.74 | 4.154 |
| Brutowinst
| 73.944 | 83.327 | 49.934 | 50.505 | 53.248 | 53.247 | 55.117 | 57.477 | 50.531 | 67.973 | 46.086 | 51.119 | 19.017 | 17.724 | 13.911 | 20.97 | 14.878 | 9.661 | 9.766 | 6.876 |
| Brutowinstmarge
| 0.797 | 0.816 | 0.767 | 0.829 | 0.852 | 0.811 | 0.82 | 0.849 | 0.834 | 0.854 | 0.818 | 0.859 | 0.568 | 0.553 | 0.521 | 0.614 | 0.679 | 0.637 | 0.63 | 0.623 |
| Onderzoek- en ontwikkelingskosten
| 18.811 | 15.525 | 11.357 | 13.597 | 15.694 | 10.523 | 9.096 | 8.257 | 28.686 | 24.82 | 23.205 | 10.916 | 5.173 | 6.779 | 4.454 | 4.287 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 4.801 | 3.131 | 2.469 | 4.146 | 4.614 | 8.34 | 6.387 | 3.661 | 2.233 | 2.251 | 2.034 | 1.47 | 5.692 | 6.218 | 5.329 | 5.546 | 6.629 | 4.664 | 2.481 | 2.297 |
| Verkoop- en marketingkosten
| 0.602 | 0.419 | 0.339 | 0.337 | 5.241 | 9.901 | 9.477 | 0.14 | 0.047 | 1.53 | 0.03 | 0.081 | 0 | 0 | 0 | 0 | 0 | 0.543 | 0.247 | 0.068 |
| Verkoop-, algemene en administratieve kosten
| 5.403 | 3.55 | 2.808 | 4.483 | 9.855 | 18.241 | 15.864 | 3.801 | 2.28 | 3.781 | 2.064 | 1.551 | 5.692 | 6.218 | 5.329 | 5.546 | 6.629 | 5.207 | 2.728 | 2.365 |
| Overige kosten
| 61.372 | 51.72 | 36.025 | 39.117 | 55.7 | 51.627 | 0 | 0 | 0 | 0 | 0 | 0.006 | 0 | 0 | 0 | 0 | 0 | 0.248 | 0.308 | 0.49 |
| Bedrijfskosten
| 66.775 | 55.27 | 38.833 | 43.6 | 65.555 | 69.868 | 64.721 | 32.08 | 55.965 | 45.759 | 33.148 | 24.67 | 10.109 | 12.922 | 9.468 | 9.786 | 14.657 | 11.473 | 8.476 | 7.643 |
| Bedrijfsresultaat
| 6.146 | 28.057 | 33.114 | 2.056 | -12.307 | -16.621 | -15.496 | 21.005 | 250.303 | 22.214 | 12.938 | 26.455 | 9.94 | 5.413 | 5.733 | 12.553 | 0.221 | -1.59 | 1.609 | -0.591 |
| Bedrijfsresultaat ratio
| 0.066 | 0.275 | 0.509 | 0.034 | -0.197 | -0.253 | -0.23 | 0.31 | 4.13 | 0.279 | 0.23 | 0.444 | 0.297 | 0.169 | 0.215 | 0.367 | 0.01 | -0.105 | 0.104 | -0.054 |
| Totaal overige inkomsten en kosten netto
| -4.615 | -3.584 | -9.111 | -8.987 | -8.997 | -0.838 | -16.936 | 6.486 | 3.987 | 86.637 | 58.733 | 0.433 | -0.847 | -0.954 | -0.416 | -0.94 | -0.068 | 2.393 | -0.298 | -0.629 |
| Inkomen voor belasting
| 1.532 | 24.473 | 24.003 | -6.931 | -21.304 | -17.459 | -32.432 | 27.491 | 254.29 | 108.851 | 71.671 | 26.888 | 9.093 | 4.459 | 5.317 | 11.613 | 0.153 | 0.803 | 1.311 | -1.22 |
| Inkomen voor belasting ratio
| 0.017 | 0.24 | 0.369 | -0.114 | -0.341 | -0.266 | -0.482 | 0.406 | 4.196 | 1.368 | 1.271 | 0.452 | 0.271 | 0.139 | 0.199 | 0.34 | 0.007 | 0.053 | 0.085 | -0.111 |
| Belastingkosten
| 6.264 | 6.968 | 2.33 | 0.97 | 3.19 | 0.598 | 0.015 | 8.151 | 6.099 | 35.529 | 2.938 | 7.564 | 1.487 | 0.852 | 1.267 | 2.212 | 0.037 | 0.94 | 0.473 | 0.977 |
| Nettowinst
| -4.932 | 17.225 | 21.672 | -7.901 | -24.494 | -18.057 | -32.447 | 19.34 | 248.192 | 73.321 | 68.733 | 19.323 | 7.606 | 3.607 | 4.05 | 9.401 | 0.116 | -0.137 | 0.838 | -2.197 |
| Nettowinstmarge
| -0.053 | 0.169 | 0.333 | -0.13 | -0.392 | -0.275 | -0.483 | 0.286 | 4.095 | 0.921 | 1.219 | 0.325 | 0.227 | 0.113 | 0.152 | 0.275 | 0.005 | -0.009 | 0.054 | -0.199 |
| WPA (Winst Per Aandeel)
| -0.31 | 1.05 | 1.29 | -0.55 | -1.67 | -1.2 | -2.19 | 1.37 | 17.6 | 5.12 | 4.81 | 1.41 | 0.53 | 0.25 | 0.3 | 0.68 | 0.009 | -0.016 | 0.33 | -0.96 |
| Verwaterde WPA
| -0.31 | 1.05 | 1.28 | -0.55 | -1.67 | -1.2 | -2.19 | 1.17 | 17.05 | 5.03 | 4.8 | 1.4 | 0.53 | 0.24 | 0.27 | 0.68 | 0.009 | -0.016 | 0.33 | -0.96 |
| EBITDA
| 24.017 | 47.504 | 40.483 | 8.091 | -9.509 | -10.749 | -27.368 | 32.966 | 6.581 | 35.709 | 22.653 | 29.548 | 12.16 | 7.422 | 7.426 | 14.154 | 1.681 | -0.098 | 2.511 | 0.202 |
| EBITDA ratio
| 0.259 | 0.465 | 0.622 | 0.133 | -0.152 | -0.164 | -0.407 | 0.487 | 0.109 | 0.449 | 0.402 | 0.496 | 0.363 | 0.232 | 0.278 | 0.414 | 0.077 | -0.006 | 0.162 | 0.018 |